Revvity (RVTY) Free Cash Flow Growth (1y) (2010 - 2026)
Revvity (RVTY) Free Cash Flow Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 51.58% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 16.06% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 112.68% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 87.85% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 23.29% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -20.33% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -21.08% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 33.01% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 5.28% |
| 10 | Revvity | 12.89 Bn | 12.03 Bn | 387.66 Mn | -14.90% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 5, 2026 | -14.90% |
| Dec 28, 2025 | 12.04% |
| Sep 28, 2025 | 20.87% |
| Jun 29, 2025 | -27.98% |
| Mar 30, 2025 | -15.21% |
| Dec 29, 2024 | 1,688.80% |
| Sep 29, 2024 | 1,081.86% |
| Jun 30, 2024 | 424.58% |
| Mar 31, 2024 | 211.17% |
| Dec 31, 2023 | 102.40% |
| Apr 2, 2023 | -85.79% |
| Apr 3, 2022 | -34.85% |
| Oct 3, 2021 | 9.17% |
| Jul 4, 2021 | 119.36% |
| Apr 4, 2021 | 1,060.68% |
| Jan 3, 2021 | 50.24% |
| Oct 4, 2020 | 112.20% |
| Jul 5, 2020 | 302.82% |
| Apr 5, 2020 | 257.05% |
| Dec 29, 2019 | 51.62% |